Vanda Pharmaceuticals Inc.

D. E. Shaw & Co., Inc. VNDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

18,600

Value ($000)

164

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	164	0.0%	18,600	12/31/2025
2025 Q3	11/14/2025	610	0.0%	122,327	9/30/2025
2025 Q2	8/14/2025	775	0.0%	164,144	6/30/2025
2025 Q1	5/15/2025	874	0.0%	190,365	3/31/2025
2024 Q4	2/14/2025	1,457	0.0%	304,146	12/31/2024
2024 Q3	11/14/2024	2,625	0.0%	559,798	9/30/2024
2024 Q2	8/14/2024	3,914	0.0%	692,736	6/30/2024
2023 Q4	2/14/2024	8,913	0.0%	2,112,125	12/31/2023
2023 Q3	11/14/2023	8,414	0.0%	1,947,739	9/30/2023
2023 Q2	8/14/2023	8,445	0.0%	1,281,478	6/30/2023
2023 Q1	5/15/2023	9,255	0.0%	1,363,097	3/31/2023
2022 Q4	2/14/2023	8,103	0.0%	1,096,435	12/31/2022
2022 Q3	11/14/2022	8,926	0.0%	903,429	9/30/2022
2022 Q2	8/15/2022	9,286	0.0%	851,978	6/30/2022
2022 Q1	5/16/2022	7,569	0.0%	669,147	3/31/2022
2021 Q4	2/14/2022	9,823	0.0%	626,060	12/31/2021
2021 Q3	11/15/2021	14,156	0.0%	825,900	9/30/2021
2021 Q2	8/16/2021	18,958	0.0%	881,347	6/30/2021
2021 Q1	5/17/2021	11,332	0.0%	754,429	3/31/2021
2020 Q4	2/16/2021	5,419	0.0%	412,459	12/31/2020
2020 Q3	11/16/2020	5,241	0.0%	542,541	9/30/2020
2020 Q2	8/14/2020	8,304	0.0%	725,904	6/30/2020
2020 Q1	5/15/2020	6,330	0.0%	611,012	3/31/2020
2019 Q4	2/14/2020	1,770	0.0%	107,893	12/31/2019
2014 Q1	5/15/2014	3,589	0.0%	220,882	3/31/2014
2013 Q4	2/14/2014	644	0.0%	51,864	12/31/2013